Catalyst – solid sorbent – or support therefor: product or process – Solid sorbent – Organic
Reexamination Certificate
2007-12-04
2007-12-04
Anthony, Joseph D. (Department: 1714)
Catalyst, solid sorbent, or support therefor: product or process
Solid sorbent
Organic
C502S402000, C502S405000, C502S407000, C502S408000, C502S415000, C502S062000, C502S063000, C502S085000, C502S087000, C435S183000, C435S174000, C435S176000, C435S178000, C435S180000, C435S182000, C435S188000
Reexamination Certificate
active
11419230
ABSTRACT:
The present invention provides compositions for the separation of metals or biomolecules such as polypeptides, nucleic acids, or endotoxins using modified solid supports.
REFERENCES:
patent: 3621018 (1971-11-01), Hindersinn et al.
patent: 4080171 (1978-03-01), Sano et al.
patent: 4220726 (1980-09-01), Warshawsky
patent: 4238328 (1980-12-01), Bowes et al.
patent: 4500494 (1985-02-01), Scher
patent: 5047513 (1991-09-01), Dobeli et al.
patent: 5175271 (1992-12-01), Thomas et al.
patent: 5217866 (1993-06-01), Summerton et al.
patent: 5250188 (1993-10-01), Bruening et al.
patent: 5700642 (1997-12-01), Monforte et al.
patent: 5922545 (1999-07-01), Mattheakis et al.
patent: 5932102 (1999-08-01), Wyllie et al.
patent: 5981194 (1999-11-01), Jefferies et al.
patent: 6106724 (2000-08-01), McCulloch et al.
patent: 6194550 (2001-02-01), Gold et al.
patent: 6207446 (2001-03-01), Szostak et al.
patent: 6242581 (2001-06-01), Nelson et al.
patent: 6296937 (2001-10-01), Pryor et al.
patent: 6379970 (2002-04-01), Liebler et al.
patent: 6428807 (2002-08-01), MacFarlan et al.
patent: 6441009 (2002-08-01), Fernandez-Pol
patent: 6479300 (2002-11-01), Jiang et al.
patent: 7005071 (2006-02-01), Andersson et al.
patent: 7067136 (2006-06-01), Jackson et al.
patent: 7083958 (2006-08-01), Sligar et al.
patent: 7105347 (2006-09-01), Fang et al.
patent: 2001/0021535 (2001-09-01), Nelson et al.
patent: 2001/0039014 (2001-11-01), Bass et al.
patent: 2001/0046680 (2001-11-01), Yu
patent: 2002/0019486 (2002-02-01), Pevow
patent: 2002/0037532 (2002-03-01), Regnier et al.
patent: 2002/0040275 (2002-04-01), Cravatt et al.
patent: 2002/0058269 (2002-05-01), Nock et al.
patent: 2002/0182651 (2002-12-01), Patricelli
patent: WO91/12079 (1991-08-01), None
patent: WO00/11208 (2000-03-01), None
patent: WO02/37100 (2002-05-01), None
patent: WO02/42398 (2002-05-01), None
Altin, J. et al., “Synthesis of the Chelator Lipid Nitrilotriacetic Acid Ditetradecylamine (NTA-DTDA) and its Use with the lasys Biosensor to Study Receptor-Ligand Interactions on Model Membranes,” Biochimica et Biophysica Acta (2001) 1513:131-148.
Barret, D.A. et al., “Resistance to nonspecific protein adsorption by poly(vinyl alcohol) thin films adsorbed to a poly(styrene) support matrix studied using surfact plasmon resonance,” Anal. Chem. (2001) 73:5232-5239.
Brandt, K.D. et al., “Structure-function relationships in indium-111 radioimmunoconjugates,” Bioconjugate Chem. (1992) 3:118-125.
Coutlet, et al. “Immobilization of enzymes on metal-chelate regenerable carriers”Biotechnology and Bioengineering, 23: 663-668 (1981).
Erdogan, S. et al., “Challenge of human jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant,” Biochemical Journal (1997) 321:165-175.
Fornasiero, D. et al., “Paramagnetic complexes of manganese(II), iron(III), and gadolinium(III) as contrast agents for magnetic resonace imaging,” Inv. Rad. (1987) 322-327.
Frenzel, et al. “Novel purification system for 6xHis-tagged proteins by magnetic affinity separation”Journal of Chromatography B, 793 (2003) 325-329.
Fujihara A. et al., “Detection of tmRNA-mediated trans-translation products inBacillus subtilis,” Genes to Cells (2002) 7:343-350.
Gavin, A-C et al., “Functional organization of the yeast proteome by systematic analysis of protein complexes,” Nature (2002) 415:141-147.
Gerber, S.A. et al., “Direct profiling of multiple enzyme activities in human cell lysates by affinity chromatography/electrospray ionization mass spectrometry: application to clinical enzymology,” Anal. Chem. (2001) 73:1651-1657.
Giriat, I. et al., “Protein Splicing and Its Applications,” Genet. Eng. (2001) 23:171-199.
Goubran-Botros, H. et al., Immobilized metal ion affinity partitioning of cells in aqueous two-phase systems: erythrocytes as a model, Biochimica et Biohysica Acta (1991) 1074:69-73.
Goubran-Botros, H. et al., “Immobilized metal ion affinity electrophoresis. A study with several model proteins containing histidine,” J. Chromotogr. (1992) 597:357-364.
Hainfeld, J.F. et al., “Ni-NTA-gold clusters target His-tagged proteins,” J. Struc. Biol. (1999) 127:185-198.
Haupt, K. et al., “Immobilized metal ion affinity capillary electrophoresis of proteins—a model for affinity capillary electrophoresis using soluble polymer-supported ligands,” Anal. Biochem. (1996) 234:149-154.
He, M. et al., “Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method),” Nuc. Acids Res. (2001) 29(15):e73 1-6.
Hermanson et al.,Immobilized Affinity Legand TechniquesAcademic Press (1992).
Hochuli, E. et al., “New Metal Chelate Adsorent Selective for Proteins and Peptides Containing Neighbouring Histidine Residues,” J. Chromatography (1987) 411:177-184.
Ito, M. et al., “Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins,” J. Biol. Chem. (1999) 274(13):9029-9037.
Kapanidis, A.N. et al., “Site-specific incorporation of fluorescent probes into protein: hexahistidine-tag-mediated fluorescent labeling with (ni2+:nitrilotriacetic acid)n—fluorochrome conjugates,” J. Am. Chem. Soc. (2001) 123:12123-12125.
KURT-Othmer Encyclopedia of Chemical Technology, vol. 21, 4th ed., Mary Howe-Grant, et al., John Wiley & Sons, p. 1021 (1997).
Laboureau, E. et al., “Concerning the separation of mammalian cells in immobilized metal ion affinity partitioning systems: a matter of selectivity,” J. Mol. Recog. (1997) 10:262-268.
Lamla, T. et al., “In vitro selection of other proteins than antibodies by means of ribosome display,” FEBS Letters (2001) 502:35-40.
Maniatis, et al. Ausubel, Molecular Cloning, Cold Spring Harbor Laboratory (1982).
Motekaitis, et al., “New multidentate ligands. XV. Chelating tendencies of diglycine-N,N-diacetic acid, triglycine-N,N-diacetic acid, and tetraglycine-N,N-diacetic acid”,Inorganic Chemistry, 13(3) 550-9 (1974).
Murata, M. et al., “Novel biosensor for the rapid measurement of estrogen based on a ligand-receptor interaction,” Anal. Sci. (2001) 17:387-390.
Nanak, E. et al., “Segregation of normal and pathological human red blood cells, lymphocytes and fibroblasts by immobilized metal-ion affinity partitioning,” J. Mol. Recog. (1995) 8:77-84.
Old et al., Principles of Gene Manipulation, 2nd ed. (1981).
Patel, D. et al., “In vitro assay for site-specific proteases using bead-attached GFP substrate,” Biotechniques (2001) 31(5):1194 (was previously cited as Frelinger et al.).
Porath, J. et al., “Metal chelate affinity chromatography, a new approach to protein fractionation,” Nature (1975) 258:598-599.
Proffitt, R.T. et al., “Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice,” J. Nucl. Med. (1983) 24(1):45-51.
Roberts, G.C. et al., “Alternative splicing: combinatorial output from the genome,” Curr. Opin. Chem. Biol. (2002) 6(3):375-383.
Thess, A. et al., “Specific Orientation and Two-dimensional Crystallization of the Proteasome at Metal-chelating Lipid Interfaces,” J. Biological Chemistry (2002) 277:39:36321-36328.
Vosters, A.F. et al., “On the engineering of rDNA proteins for purification by immobilized metal affinity chromatography: applications to alternating histidine-containing chimeric proteins from recombinantEscherichia coli,” Prot. Express. Purif. (1992) 3:18-26.
Xu, Y. et al., “A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins,” PNAS (1999) 9
Flemming Roderick G.
Johnson Tonny M.
Simpson Daniel J.
Anthony Joseph D.
Michael & Best & Friedrich LLP
Promega Corporation
LandOfFree
Compositions for separating molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for separating molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for separating molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3832068